Neurology 2013-11 - Neurology Alert - Nov 01, 2013

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Claire Henchcliffe, MD, PhD
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College

Dara Jamieson, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Alan Z. Segal, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Authors
Elayna Rubens, MD
Assistant Professor of Neurology,
Weill Cornell Medical College

Sotirios Keros, MD, PhD
Instructor, Department of Pediatrics,
Division of Pediatric Neurology,
Weill Cornell Medical College

Dara Jamieson, MD
Associate Professor of Clinical Neurology,
Weill Cornell Medical College

Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience, Comprehensive
Epilepsy Center, Weill Cornell Medical College

Michael Rubin, MD
Professor of Clinical Neurology,
Weill Cornell Medical College

Subjects:

  • Levetiracetam Is Not Better than Older Antiepileptic Drugs as Initial Monotherapy for Newly Diagnosed Epilepsy
  • Maternal Hypothyroxinemia and Autism
  • Headaches – A Hidden Disability Associated with Seizures
  • Seizure Characteristics in Early-stage AD
  • Botulinum Toxin for Postherpetic Neuralgia

Objectives:

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Authors Dr. Rubens , Dr. Keros, Dr. Kandula and Dr. Rubin report no financial relationships relevant to this field of study.

Author Dr. Jamieson reports she is a retained consultant for Boehringer Ingelheim and Bayer, and is on the speakers bureau for Boehringer Ingelheim.